Transforming growth factor-β1 inhibits prolactin secretion and lactotropic cell proliferation in the pituitary of oestrogen-treated fischer 344 rats

Neurochemistry International

Volumn 30, Issue 4-5, 1997, Pages 499-506

  Minami, S ^a   Sarkar, D K ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; PROLACTIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; FEMALE; HYPOPHYSIS; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT;

ANIMALS; CELL DIVISION; ESTRADIOL; ESTROGENS; FEMALE; OVARIECTOMY; PITUITARY GLAND, ANTERIOR; PROLACTIN; RATS; RATS, INBRED F344; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0030949823     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00087-3     Document Type: Article

References (43)

1. Banerjee, S. K., De, A. and Sarkar, D. K. (1994) Colocalization of prolactin and proliferating cell nuclear antigen in the anterior pituitary during oestrogen-induced pituitary tumors. Cancer Lett. 87, 139-144.
2. Billestrup, N., Gonzalez-Manchon, C., Potte, E. and Vale, W. (1990) Inhibition of somatotroph growth and growth hormone biosynthesis by activin in vitro. Mol. Endocrinol. 4, 356-362.
3. Burns, G. and Sarkar, D. K. (1993) Transforming growth factor-β1-like immunoreactivity in the pituitary gland on the rat: effect of oestrogen. Endocrinology 133, 1444-1449.
4. Cheifetz, S., Ling, N., Guillemin, R. and Massague, J. (1988) A surface component on GH3 pituitary cells that recognizes transforming growth factor β, activin, and inhibin. J. Biol. Chem. 263, 17225-17228.
5. De, A., Boyadjieva, N.Iv., Pastorcic, M. and Sarkar, D. K. (1995) Potentiation of the mitogenic effect of oestrogen on the pituitary gland by alcohol consumption. Int. J. Oncol. 7, 643-648.
6. 125I]TGF-β1-binding sites. Journal of Endocrinology 149, 19-27.
7. Derynick, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., Bell, J. R., Assoian, R. K., Roberts, A. B., Sporn, M. B. and Goeddel, D V. (1985) Human transforming growth factor β complementary DNA sequence and expression in normal and transformed cells tumor cell lines. Nature 316, 701-705.
8. Dickson, R. B. and Lippman, M. R. (1987) Oestrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr. Rev. 8, 29-43.
9. Dluzen, D. E. and Ramirez, V. D. (1987) In vivo activity of the LHRH pulse generator as determined with push-pull perfusion of the anterior pituitary gland of unrestrained intact and castrated male rats. Neuroendocrinology 45, 328-332.
10. El Etreby, M. F. (1980) The role of contraceptive steroids in pathogenesis of tumors in various experimental animals and in man. In Pituitary Microadenomas, ed. Faglia G., Giovanelli M. A. and Macleod R. M., pp. 211-222. Academic Press, New York.
11. Furth, J. (1969) Pituitary cybernetics and neoplasia. Harvey Lect. 63, 47-71.
12. Gooren, L. J., Assies, J., Asscheman, H., de Siegte, R. and ven Kessel, H. (1988) Oestrogen-induced prolactinomas in a man. J. Clin. Endocrinol. Metab. 66, 444-448.
13. Ignotz, R. and Massague, J. (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into extracellular matrix. J. biol. Chem. 261, 4337-4345.
14. Keski-Oja, J., Leof, E. B., Lyons, R. M., Coffey, R. J. Jr. and Mosses, H. L. (1987) Transforming growth factors and control of neoplastic cell growth. J. Cell. Biochem. 33, 95-107.
15. Kitaoka, M., Kojima, I. and Ogata, E. (1988) Activin-A: a modulator of multiple types of anterior pituitary cells. Biochem. Biophys. Res. Commun. 157, 48-54.
16. Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R. and Dickson, R. B. (1987) Evidence that transforming growth factor β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48, 417-428.
17. Lawrence, D. A., Pircher, R., Kryce-Martinerie, C. and Jullien, P. (1984) Normal embryo fibroblast releases transforming growth factors in a latent form. J. Cell. Physiol. 121, 184-188.
18. Lloyd, H. M., Meares, J. D. and Jacobi, J. (1975) Effects of ooestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells. Science 255, 497-498.
19. Meunier, H., Rivier, C., Evans, R. M. and Vale, W. (1988) Gonadal and extragonadal expression of inhibin α, βA, and βB subunits in various tissues predicts diverse functions. Proc. Natl. Acad. Sci. U.S.A. 85, 247-251.
20. Minami, S., Frautschy, S. A., Plotsky, P. M. and Sarkar, D. K. (1990) Facilitatory role of neuropeptide Y on the onset of puberty: Effect of immunoneutralization of neuropeptide Y on the release of luteinizing hormone and luteinizing-hormone-releasing hormone. Neuroendocrinology 52, 112-115.
21. Moses, H. L., Tucker, R. F., Leof, E. B., Coffey, R. J. Jr., Halper, J. and Shipley, G. D. (1985) Type-beta transforming growth factor is a growth stimulator and a growth inhibitor. In Cancer Cells, ed. Feramisco J., Ozanne B. and Stiles C., Vol. 3, pp. 65-71. Cold Spring Harbor Press, New York.
22. Pastorcic, M., De, A., Boyadjieva, N., Vale, W. Sar, Sarkar, D. K. (1995) Reduced transforming growth factor β1 expression and function in the lactotropes during oestrogen-induced tumorigenesis. Cancer Res. 55, 4892-4898.
23. Postlethwaite, A. E., Keski-Oja, J., Moses, H. L. and Kang, A. H. (1987) Stimulation of the chemotactic migration of human fibroblast by transforming growth factor β. J. Exp. Med. 165(1), 251-256.
24. Prysor-Jones, R. A., Silverlight, J. J. and Jenkins, J. S. (1989) Oestradiol, vasoactive intestinal peptide and fibroblast growth factor in the growth of human pituitary tumor cells in vitro. J. Endocrinol. 120, 171-177.
25. Ramsdell, J. S. (1991) Transforming growth factor a and β are potent and effective inhibitors of GH4 pituitary tumor cell proliferation. Endocrinology 128, 1981-1990.
26. Raymond, V., Beaulieu, M. and Labrie, F. (1978) Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Science 200, 1173-1175.
27. Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F. and Sporn, M. B. (1985) Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. U.S.A. 82, 119-123.
28. Roberts, A. B. and Sporn, M. B. (1990) The transforming growth factor-betas. In Peptide Growth Factors and Their Receptors: Handbook of Experimental Pharmacology, ed. Sporn M. B. and Roberts A. B., Vol. 95, pp. 410-472. Springer-Verlag, Heidelberg.
29. Sarkar, D. K., Gottschall, P. E. and Meites, J. (1982) Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting tumors. Science 218, 684-686.
30. Sarkar, D. K., Gottschall, P. E. and Meites, J. (1983) Relation of the neuroendocrine system to development of prolactin secretion pituitary tumors. In Neuroendocrinology of Aging, ed. Meites J., pp. 353-376. Plenum Press, New York.
31. Sarkar, D. K., Kim, K. H. and Minami, S. (1992) Transforming growth factor-β1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth. Mol. Endocrinol. 6, 1825-1833.
32. Sarkar, D.K., Pastorcic, M., De, A. and Boyadjieva, N. (1995) Dopamine increases transforming growth factor-β1 synthesis and secretion in the anterior pituitary gland. Soc. Neurosci. Abstr. 21, 405.10.
33. Schechter, J. E., Felicio, L. S., Nelson, J. F. and Finch, C. E. (1981) Pituitary tumorigenesis in aging female C57BL/6J mice: a light and electron microscopic study. Anat. Rec. 199, 423-432.
34. Scheithauer, B. W., Kovacs, K. T., Laws, E. R. and Randall, R. V. (1986) Pathology of invasive pituitary tumors with special reference to functional classification. J. Neurosurg. 65, 733-744.
35. Schonbrunn, A., Krasnoff, M., Westendorf, J. M., Tashjian, A. H. Jr. (1980) Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhibition of cell proliferation. J. Cell Biol. 85, 786-792.
36. Shewchuck, A. B., Adamson, G. D., Lessard, P. and Ezrin, C. (1980) The effect of pregnancy on suspected pituitary adenomas after conservative management of ovulation defect associated with galactorrhea. Am. J. Obst. Gynecol. 136, 659-666.
37. Sirbasku, D. A. (1978) Oestrogen induction of growth factors specific for hormone responsive mammary, pituitary and kidney tumor cells. Proc. Natl. Acad. Sci. U.S.A. 75, 3786-3790.
38. Soto, A. M. and Sonnenschein, C. (1987) Cell proliferation of oestrogen-sensitive cells: the case for negative control. Endocr. Rev. 8, 44-52.
39. Thompson, N. L., Flanders, K. C., Smith, J. M., Ellingsworth, L. R., Roberts, A. B. and Sporn, M. B. (1989) Expression of transforming growth factor-β1 in specific cells and tissues of adult and neonatal mice. J. Cell Biol. 108, 661-679.
40. Vale, W., Rivier, J., Vaughan, J., McClintock, R., Corrigan, A., Woo, W., Karr, D. and Spiess, J. (1986) Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321, 776-779.
41. von Werder, K. (1985) Recent advances in diagnosis and treatment of hyperprolactinemia. In: The Pituitary Gland (Imura H., ed.), pp. 405-410. Raven Press, New York..
42. Ward, J. M., Hagiwara, A., Anderson, L. M., Lindsey, K. and Diwan, B. A. (1988) The chronic hepatic or renal toxicity of di(2-ethylhexyl)phthalate, acetaminophen, sodium barbital and pentobarbital in male B6C3F1 mice: autoradiographic, immunohistochemical and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis or tumor promotion. Toxicol. Appl. Pharmacol. 96, 494-506.
43. Wiklund, J. A., Wertz, N. and Gorski, J. (1981) A comparison of oestrogen effect on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology 109, 1700-1707.